Side-by-side comparison of AI visibility scores, market position, and capabilities
Flagship Pioneering-backed scientific superintelligence. Fully autonomous AI labs. $550M raised ($115M from Nvidia). $1.3B+ valuation. Founded 2024, Cambridge MA.
Lila Sciences is a scientific superintelligence company founded in 2024 and headquartered in Cambridge, Massachusetts, with the mission of building fully autonomous AI systems capable of conducting original scientific research. Backed by Flagship Pioneering — the venture creation firm behind Moderna — Lila Sciences is pursuing one of the most ambitious mandates in AI: replacing the human-in-the-loop in the scientific method with AI that can hypothesize, design experiments, interpret results, and iterate without continuous human direction.\n\nLila Sciences operates autonomous AI laboratories that handle the full research cycle: hypothesis generation, experimental design, robotic execution, data analysis, and scientific interpretation. The company is focused initially on life sciences and biology, where the combinatorial search space for drug discovery and therapeutic development has historically been a bottleneck that AI is uniquely suited to accelerate. Unlike AI tools that assist scientists, Lila's systems are designed to function as independent research agents, with human scientists setting research goals and reviewing outputs rather than directing every step.\n\nLila Sciences has raised $550 million in total funding, including $115 million from NVIDIA, reaching a valuation exceeding $1.3 billion. NVIDIA's investment reflects both the compute demands of autonomous lab systems and strategic alignment with the vision of AI-accelerated science. The company is among the best-funded scientific AI startups globally and one of a small cohort — alongside Isomorphic Labs and Genesis Therapeutics — building toward fully autonomous scientific discovery. Its Flagship Pioneering pedigree and early-stage capitalization give Lila a multi-year runway to prove the autonomous research paradigm.
AI quality assurance with insurance-backed warranties from Swiss Re and Greenlight Re; EU AI Act compliance assessments backed by YC and reinsurance partners for high-risk AI deployments.
Armilla AI is a third-party AI quality assurance and warranty company that evaluates AI models for organizations deploying AI in regulated or high-stakes contexts — assessing models against EU AI Act and NIST AI Risk Management Framework requirements for risks including bias, hallucination, robustness failures, and adversarial vulnerabilities, then providing performance guarantees backed by insurance coverage from reinsurers Swiss Re, Greenlight Re, and Chaucer. Founded in Toronto, Canada, Armilla raised $6.81 million total including a C$4.5 million seed round in February 2024 from Mistral Venture Partners, MS&AD Ventures, Y Combinator, and its reinsurance partners.\n\nArmilla's model is unique in the AI governance market — rather than just providing compliance reports, Armilla backs its assessments with insurance warranty products. An enterprise deploying a third-party AI model can purchase an Armilla warranty that pays out if the model performs differently than assessed (fails on bias, accuracy, or robustness metrics), transferring AI performance risk to insurance markets that can price and distribute it. This insurance mechanism creates financial accountability for AI quality claims that audit reports alone don't provide.\n\nIn 2025, Armilla competes in the AI governance, risk, and compliance market with Credo AI, Arthur AI, and AI audit firms for enterprise AI risk assessment and compliance tools. The EU AI Act, fully applicable by August 2025 for high-risk AI systems, is driving enterprise compliance urgency — companies deploying AI in hiring, credit scoring, healthcare, and other regulated contexts need third-party conformity assessments. Armilla's insurance-backed warranty differentiates its offering from pure advisory competitors. The reinsurer backing (Swiss Re, Greenlight Re, Chaucer) provides both capital credibility and distribution through insurance broker channels. The 2025 strategy focuses on growing EU AI Act compliance assessments and expanding the warranty product coverage to more AI deployment use cases.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.